YMAB Y-mAbs Therapeutics Chart, History Price & Graph

a developer of novel antibody therapeutics for oncology targets

Industry: #Pharmaceuticals Major

Get AI intraday signals

A.I.Advisor

published price charts

These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period.

View AI-Driven Trading for YMAB

View a ticker or compare two or three

Compare

Interact to see
Advertisement